About Us

---

Maria Marmarinos has negotiated a broad range of transactions ranging from private placements to licensing, joint ventures, and mergers and acquisitions. Prior to creating Catalyst Group, she was a co-founder, Executive Vice President Strategic Planning & Corporate Development, and Treasurer of NitroMed, Inc. Ms. Marmarinos served as the 

Maria Marmarinos has negotiated a broad range of transactions ranging from private placements to licensing, joint ventures, and mergers and acquisitions. Prior to creating Catalyst Group, she was a co-founder, Executive Vice President Strategic Planning & Corporate Development, and Treasurer of NitroMed, Inc. Ms. Marmarinos served as the Executive Vice President of Strategic Planning & Corporate Development for Sequella, Inc. Ms. Marmarinos also served as AVP of Ventures at Brigham and Women’s Hospital, Boston. Previously, she was a Worldwide Marketing Development Manager, Immunoassay Diagnostics, at Corning Medical and Ciba Corning Diagnostics. Ms. Marmarinos was an Instructor of Medical Microbiology at Nassau College in New York. She is a Member of the Corporation of Partners Healthcare, Inc.; a Member of the Board of Overseers of Brigham and Women’s Hospital; and a Member of the Leadership Council of the Biomedical Research Institute at Brigham and Women’s Hospital. Ms. Marmarinos serves as a faculty member of Harvard Catalyst presenting a CME credited course – Medical Device and Diagnostics Development: A Practical Approach to Validation and Commercialization, since 2013 

 Dr. Charles Hoyng provides advice and counsel regarding intellectual property, business strategy, and product development issues, for life science, biotechnology and pharmaceutical companies. Previously, Dr. Hoyng was a Partner in Latham & Watkins’ Silicon Valley and Boston offices and a member of the Intellectual Property and Technology

 Dr. Charles Hoyng provides advice and counsel regarding intellectual property, business strategy, and product development issues, for life science, biotechnology and pharmaceutical companies. Previously, Dr. Hoyng was a Partner in Latham & Watkins’ Silicon Valley and Boston offices and a member of the Intellectual Property and Technology Practice Group. Prior to joining Latham & Watkins, Dr. Hoyng was a partner in the San Francisco office of Morrison & Foerester LLP.  Dr. Hoyng's legal and business practice consists of negotiating and drafting technology license agreements and other agreements, and counseling in the development, protection, manufacture and distribution of high technology products, particularly in the areas of biotechnology, pharmaceutical products, medical diagnostic products, medical devices and health care related businesses. He served as lead attorney on several significant transactions including GlobeImmune/Cellgene, GlobeImmune/Gilead, Chiron/StarBio, Eli Lilly/United HealthCare, Allergan/Medytox; Allergan/ GSK, Oncomed/GSK among many others. After earning his Ph.D. at M.I.T. and prior to earning his law degree, Dr. Hoyng was a post-doctoral research fellow at Caltech (the California Institute of Technology), Pasadena, California, an Assistant Professor of Chemistry at Texas A&M University, and held several positions at Genentech, Inc., including Director, Organic Chemistry, and Project Director for Genentech's tissue plasminogen activator (t-PA) project. 

Anne Zacarian offers professional experience distinguished by solid management, marketing strategy, sales and business development, leveraged to drive efficiency, effectiveness and accelerate ROI while identifying new revenue streams. She crosses industries and social enterprise sectors with versatility and agility. Ms. Zacarian has been 

Anne Zacarian offers professional experience distinguished by solid management, marketing strategy, sales and business development, leveraged to drive efficiency, effectiveness and accelerate ROI while identifying new revenue streams. She crosses industries and social enterprise sectors with versatility and agility. Ms. Zacarian has been twice ranked corporately as the highest woman executive at BMW of North America and Sony of North America. Her diverse career spans the spectrum from new ventures, and mid-size to mature b2b/b2c operations to include coveted strategic planning services for the Vatican, NASA & International Space Station and the Olympics. She is well respected for her mentoring and role as a competition judge at top business schools and innovation labs. 

Larry Fitzmaurice provides expert services by identifying and implementing financial management practices, rules, and tools for newly created and emerging companies. His distinguished background includes serving as Massachusetts State Comptroller, and later as State Revenue Commissioner for the Commonwealth of Massachusetts. He has extens

Larry Fitzmaurice provides expert services by identifying and implementing financial management practices, rules, and tools for newly created and emerging companies. His distinguished background includes serving as Massachusetts State Comptroller, and later as State Revenue Commissioner for the Commonwealth of Massachusetts. He has extensive experience in the banking sector with a 20-year career at State Street Corporation and holding various financial management positions, including Corporate Controller and Vice President of Finance. Larry served as President and CEO of the New England Center for Homeless Veterans, for which he was recognized as a leader in social entrepreneurship. He is an Entrepreneurial Leader, Industrial Management, for Entrepreneurship of All Kinds® at Babson College. Mr. Fitzmaurice is a proud veteran of the United States Marines Corps.